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a b s t r a c tThe aim of this study was to investigate how self-assessments of perceived distress and quality of life in patients
with schizopsychotic illness are associatedwith nurse assessments of symptoms, function and life situation. Data
were obtained through interviews that used evidence-based rating and visual analogue self-rating scales.
Descriptive statistics, correlation and regression analyseswere used to process the data. The results demonstrated
that the patient self-ratings did not correlate with the nurse assessments, and the perceived distress was not
affected by remission status. The ﬁndings indicate that patient self-assessments are not a sufﬁcient basis for
decisions regarding appropriate treatment interventions.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).BACKGROUND
Outpatient Care and Schizopsychotic Illness
Globally, approximately 25million individuals are estimated to suffer
from the most common form of psychotic illness, schizophrenia. Schizo-
phrenia is as frequent and constant for all countries and cultures; it afﬂicts
0.3%–0.5% of the population, and the lifetime risk of developing schizo-
phrenia is approximately 1% (Piccenelli & Gomez Homen, 1997; World
HealthOrganization, 2013). In this study, the term schizopsychotic illness
denotes schizophrenia, schizoaffective disorder and delusional disorder.
In Sweden, outpatient care provides the primary treatment for patients
with schizopsychotic illness who live in independent housing. It is esti-
mated that 30,000–40,000 individuals are in need of community inter-
ventions because of schizopsychotic illness. In Sweden, the total cost for
these illness groups amounts to 62,500 Euro per patient per year
(Hjortsberg, Helldin, Hjärthag, & Löthgren, 2011). Patientswith psychotic
illness risk long hospitalizations, which affect their normal lives. For
example, hospitalizationsmay lead to theneed to regain certain functions
following discharge (Tanioka, Mano, Takasaka, Tada, & Kawanishi, 2006).
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hospitalization, i.e., the so-called avoidable hospital admissions (Bianco
et al., 2012; Woodhams et al., 2012).
Symptoms and Functional Capacity
Hallucinations and delusions are two classic psychotic symptoms,
which are referred to as positive symptoms in psychiatric care
(Waters, 2010). Psychotic illness also includes negative symptoms,
such aswithdrawal and the lack of spontaneity andﬂowof conversation
(American Psychiatric Association, 2013; Kring, Gur, Blanchard, Horan,
& Reise, 2013). In addition, there are general symptoms, such as
disorientation and poor attention, judgment, and insight. The degree
of these symptoms depends on the severity of the illness and the pa-
tient’s physiological condition (Gerretsen et al., 2013; McFarland et al.,
2013). For many patients, the illness leads to the loss of social and intel-
lectual capacities, blunted affects, and lack of interest in one’s life and
context (Kay, Fiszbein, & Opler, 1987; Lindström, Wieselgren, & von
Knorring, 1994). These losses, in turn, lead to reduced functional capacity.
Thus, a relevant assessment of the patient’s state is crucial to provide an
effective intervention (Socialstyrelsen, 2003).
Assessment and Self-Assessment of Psychotic Illness
The term remission is used to obtain a qualitative treatment goal for
patients with schizophrenia. Remission indicates that the patient’s
symptoms are so mild that they do not affect function (Andreasenthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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demonstrated that patients in stable remission have higher functional
capacity compared with patients not in remission (Emsley, Chiliza,
Asmal, & Lehloenya, 2011; Helldin, Kane, Karilampi, Norlander, &
Archer, 2007). Other studies have shown that patient quality of life
and satisfaction with care are higher if the patient has achieved remis-
sion (Helldin, Kane, Karilampi, Norlander, & Archer, 2008).
However, recent ﬁndings show that accurate self-assessments of
cognition and everyday function are often difﬁcult to accomplish for pa-
tients with schizophrenia (Durand et al., 2015; Gould et al., 2015).
When comparing assessments made by professionals with self-
assessments made by patients regarding everyday function, the profes-
sionals’ assessments correlated with objectivemeasures of function to a
higher extent compared with the patients’ self-assessments (Sabbag
et al., 2011). Also, predictors of self-rating abilities for patients with
schizophrenia have recently been investigated, indicating that patients
with more depressive symptoms may be more accurate in their ratings
of everyday function (Sabbag et al., 2012). Hence, the use of self-
assessments for patients with a schizopsychotic illness is a complex
issue, and perhaps part of why there are divergent ﬁndings about the
relationship between patients’ quality of life and symptom activity
(Eack & Newhill, 2007).
Studies regarding how assessments performed by staff correlate
with patient self-assessments have primarily been conducted in somatic
care and inpatient care (Higginson & Gao, 2008; Kamdar et al., 2012;
Sandhaug, Andelic, Berntsen, Seiler, &Mygland, 2012; To, Ong, Rawlings,
Greene, & Currow, 2012). Consequently, few studies have compared
self-assessments with assessments in psychiatric outpatient care. This
study examines how self-assessments of perceived distress and quality
of life in patients with a schizopsychotic illness correlate with nurse as-
sessments of symptoms, functioning, and social situations. The aim of
this study was to investigate how self-assessments of perceived distress
and quality of life in patients with schizopsychotic illness are associated
with nurse assessments of symptoms, function and life situation.
METHODS
The data for this study were collected from the ongoing research
project Clinical Long-term Investigation of Psychosis in Sweden
(CLIPS), which is conducted in outpatient care and includes approxi-
mately 250–300 patients annually. CLIPS is an exploratory longitudinal
project initiated in 2000 in which, among other things, patients rate
their distress and quality of life, while nurses evaluate patient symp-
toms and cognitive functioning (Helldin, Kane, Karilampi, Norlander, &
Archer, 2006; Karilampi, Helldin, Hjärthag, Norlander, & Archer, 2007).
Inclusion and Exclusion Criteria
Patients with a schizopsychotic illness such as schizophrenia,
schizoaffective disorder, and delusional disorder according to DSM-IVTable 1
Demographical Characteristics of the Sample, When Remission Status Was Considered.
Variable Rem
(n =
Gender Men 108
Women 64
Civil statusa Single without previous relationship 106
Married or cohabiting 32
Single with a previous relationship 33
Educational levelb Primary education 72
Secondary education 66
Higher education 29
Note. Each cell shows number of individuals and corresponding row-percentages. Chi-square t
a Information from 1 participant was missing.
b Information from 8 participants were missing.(American Psychiatric Association, 1994), were included in the study.
The dual diagnoses abuse, dementia, and intellectual disability were
criteria for exclusion, because the patients had to be capable of under-
standing the research information, give their consent, and conduct
self-assessments. Signed informed consent was obtained from all par-
ticipants. All participants were informed about the study, that participa-
tion was voluntary, that conﬁdentiality was guaranteed, and that they
could withdraw from the study at any time without any explanation
(Polit & Beck, 2011; World Medical Association, 2008). The study was
carried out following the ethical guidelines of the latest Helsinki
declaration and was approved by the Regional Ethical Review Board
at the University of Gothenburg, Sweden, on July 5, 2010 [Approval
number: 438-10].
Participants
All patients (n = 274) assessed in the CLIPS project in 2011, diag-
nosed with either schizophrenia (n = 175), schizoaffective disorder
(n=68), or delusional disorder (n=31), and all nurseswho conducted
the assessments (n= 28) were included in this study. The patient sam-
ple included 112 women with a mean age of 55 (SD = 13) years, and
162 men with a mean age of 51 (SD = 11) years. The mean age of the
men was signiﬁcantly lower (independent t-test, 5% level) than the
mean age of the women. The mean age for the whole sample was 53
years (range 22–81 years). The patients were divided into two groups:
remission (n = 172) and non-remission (n = 102). The distribution
of gender, civil status levels and educational levels (highest completed
level at our baseline assessment) did not differ signiﬁcantly (chi-square
tests, 5% level) regarding remission status (Table 1).
All study participants were outpatients in a stable phase of their ill-
ness. They participated in annual surveys where they conducted self-
assessments and had trained staff assess their condition using
established assessment instruments.
Instruments
Self-Assessment Instruments—Completed by Patients
The Perceived Global Distress Scale (PGD) is a visual analogue scale;
patients rate their mental health problems based on the question
“How much have you been bothered by your psychiatric problems
during the last month?”; patients draw a mark on a 100 mm long line,
and a score is generated (Everitt & Wykes, 2010). A score of 1 implies
extremely severe distress, whereas a score of 100 indicates that the
patient does not experience any distress at all (Ivarsson, Lindström,
Malm, & Norlander, 2011).
The Global Quality of Life Scale (GQL) is a visual, analogue scale; pa-
tients assess their perceived quality of life based on the question “How
do you ﬁnd your life situation right now?” Similar to the PGD, a score
is generated on a 100-point scale (Everitt & Wykes, 2010). A score of 1
implies the poorest quality of life, and a score of 100 indicates that theission
172)
Non-remission
(n = 102)
Total sample
(n = 274)
p
(67%) 54 (33%) 162 0.109
(57%) 48 (43%) 112
(64%) 61 (36%) 167 0.288
(70%) 14 (30%) 46
(55%) 27 (45%) 60
(61%) 46 (39%) 118 0.295
(62%) 41 (38%) 107
(71%) 12 (29%) 41
est was conducted for each variable and p-values are presented.
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Lindström, & Norlander, 2010).
Interview Manuals and Assessment Tools—Completed by Nurses
The Structured Clinical Interview for the Positive and Negative
Syndrome Scale (SCI-PANSS) consists of an interview guide and an as-
sessment instrument to identify symptoms of psychotic illness. Based
on the interview responses, a professional assessment is conducted
with the PANSS assessment instrument, which measures positive
(7 items), negative (7 items), and general symptoms (16 items) of psy-
chotic illness. Each symptom is rated for the level of symptom severity
on a 7-point scale; a score of 1 implies the absence of symptoms, a
score of 2–3 implies that the symptoms do not affect functioning, and
a score of 4–7 indicates the extent to which symptoms affect functioning.
Thus, a high score implicates higher symptom severity and, consequently,
lower functioning (Kay et al., 1987; Lindström et al., 1994). For this
study, internal consistency (Cronbach’s Alpha) was 0.79 for the PANSS
positive dimension, 0.90 for the PANSS negative dimension, and 0.83
for the PANSS general dimension.
The Global Assessment of Functioning Scale (GAF) describes patients’
mental, social, and functional abilities. It encompasses two scales: one
scale describes the current symptom state (GAF-S) and one scale de-
scribes functioning (GAF-F). Each scale has 100 steps; one represents
the lowest possible functioning, and 100 represents the highest overall
functioning, which indicates the patient has no symptoms or functional
impairment (American Psychiatric Association, 2013; Luborsky, 1962).
The Strauss–Carpenter Scale, modiﬁed version (S-C) describes pa-
tients’ life situations in the following ﬁve domains: current housing sit-
uation, social contacts, capacity to work, number of days in supported
housing and hospitalization in the previous twelve months. Each of
the ﬁrst three questions has four different response alternatives, where-
as the answers to the last two questions are provided in an exact num-
ber of days of supported housing and hospitalization, respectively. The
data are collected directly from patient interviews and medical records,
as well as family members and caregivers. The original Strauss–
Carpenter scale (Strauss & Carpenter, 1972)wasmodiﬁed by Lindström,
Eriksson, Hellgren, von Knorring, and Eberhard (1995).
The Remission Scale in Schizophrenia-Symptom (RS-S) is an assess-
ment instrument based on the assessment of eight speciﬁc symptoms,
which are included in the PANSS, and indicates if the patient is in remis-
sion. To be in remission according to the RS-S criteria, the highest score
allowed is three, and the patient must have been in a stable state for the
previous six months (Andreasen et al., 2005; Lasser et al., 2007; van Os
et al., 2006).
Data Collection
The participating nurses conducted individual, semi-structured in-
terviews (SCI-PANSS) and assessed patient interview responses and
clinical observations from patient visits to the psychiatric outpatient
clinic (PANSS, GAF, and S-C). The assessment questions covered diffe-
rent areas, such as how patients experienced their symptoms, cognitive
and functional impairments, and their current life situations. Following
the nurses’ instructions, the patients conducted self-assessments (PGD
and GQL) using validated scales.
Data Analysis
Statistical calculationswere conducted in the formof correlation and
regression analyses to compare patient self-assessments with nurse
assessments. Correlation analyses were conducted between PGD
(distress), GQL (quality of life), the PANSS dimensions (positive, negative,
and general symptoms), GAF-S (symptoms), GAF-F (functioning), and S-C
(days of hospitalization, housing situation, capacity to work, and social
contacts). Signiﬁcance tests for the dependent variables PGD (distress)and GQL (quality of life) were conducted with independent t-tests
using remission status as the independent variable. Regression analyses
were conducted with the PGD and GQL, respectively, as the dependent
variables, and the PANSS, GAF, and S-C dimensions as the independent
variables. Signiﬁcance was tested at the 5% and 1% levels (Field, 2011;
Polit & Beck, 2011).
RESULTS
The correlations between the patient self-assessments (PGD and
GQL) and the nurse assessments (PANSS, GAF, and S-C) were weak
overall (r=− .004 to r =− .187). The correlations were stronger for
variables solely assessed by the nurses (from r=− .024 to r=.867), es-
pecially for instruments that measure symptoms and functioning
(PANSS and GAF; Table 2). However, a signiﬁcant correlation was
identiﬁed between the patient self-assessments of quality of life and
the patient distress ratings (r= .240, p b .01).
The differences in the mean values of PGD and GQL between the
remission group (n = 172) and non-remission group (n = 102) were
analyzed. Concerning the variables rated by these two patient groups
(PGD and GQL), only a signiﬁcant difference in quality of life was
identiﬁed between the groups: the remission group reported a higher
quality of life (Table 3).
Perceived Distress
A regression analysis was conducted to test if the variance in the pa-
tients’ self-assessed distress (PGD) could be explained by the variance in
how the nurses had assessed symptoms, functioning, and current life
situations. The analysis (stepwise) was conducted for thewhole patient
sample; PGD (distress), assessed by the patients, was the dependent
variable, and the nurse-assessed variables, i.e., the PANSS (positive, ne-
gative and general symptoms); GAF-S (symptoms); GAF-F (functioning);
and S-C (days of hospitalization, housing situation, capacity to work, and
social contacts), were the independent variables. However, a signiﬁcant
regression model could not be established for PGD.
Quality of Life
A regression analysis (stepwise) was conducted for all patients with
a self-assessed GQL (quality of life) as the dependent variable and the
nurse-assessed variables PANSS (positive, negative and general symp-
toms); GAF-S (symptoms); GAF-F (functioning); and S-C (days of hospi-
talization, housing situation, capacity to work, and social contacts) as the
independent variables. The analysis resulted in two steps (Adjusted
R2= .052, F (2, 252)= 7.97, p b .001). In the second step, themodel in-
cluded the following variables to explain the GQL: PANSS general symp-
toms (Beta = − .34) and PANSS negative symptoms (Beta = .22).
However, the model only explained 5.2% of the variance; there were
no problems with collinearity (Tolerance= .50).
DISCUSSION
The results of this study highlight the lack of correlation between pa-
tient self-ratings and nurse ratings. A previous study that investigated a
smaller number of older outpatients with schizophrenia demonstrated
that patient self-ratings tend to correlate poorly with staff ratings
(Bowie et al., 2007). Compared to Bowie et al. (2007), this study had a
larger population of patients and a wider range of ages. Furthermore,
the patients were at the time of the survey in a stable phase of their ill-
ness. Thus, our patient group should have had optimal conditions to
provide descriptions of their situation through self-assessments. How-
ever, despite the differences between the study samples of the two
studies, similar results were obtained. In addition, our patients’ remis-
sion status did not affect our study results, and our ﬁnding that patients
in remission experienced a better quality of life compared with patients
Table 2
Correlations Between Study Variables for the Entire Cohort.
PGD GQL PANSS
positive
PANSS
negative
PANSS
general
GAF-S
symptoms
GAF-F
functioning
S-C days of
hospitalization
S-C housing
arrangements
S-C capacity
to work
S-C social
contacts
PGD 1
GQL .240⁎⁎ 1
PANSS positive − .030 − .143⁎ 1
PANSS negative .009 − .049 .455⁎⁎ 1
PANSS general − .100 − .187⁎⁎ .656⁎⁎ .706⁎⁎ 1
GAF-S symptoms .026 .065 − .498⁎⁎ − .392⁎⁎ − .414⁎⁎ 1
GAF-F functioning .030 .087 − .365⁎⁎ − .410⁎⁎ − .379⁎⁎ .867⁎⁎ 1
S-C days of hospitalization − .008 − .054 .095 − .133⁎ − .127⁎ − .116 − .145⁎ 1
S-C housing arrangements .076 .032 − .119 − .145⁎ − .170⁎⁎ .257⁎⁎ .267⁎⁎ − .048 1
S-C capacity to work .088 .087 − .064 − .124⁎ − .136⁎ .287⁎⁎ .407⁎⁎ − .116 .076 1
S-C social contacts − .004 .039 − .147⁎ − .388⁎⁎ − .251⁎⁎ .268⁎⁎ .270⁎⁎ − .024 .100 .104 1
Note. Pearson’s r for PGD, GQL, PANSS positive, negative and general symptoms, GAF symptoms, GAF functioning and S-C days of hospitalization. Spearman’s rho for S-C housing arrange-
ments, capacity to work, and social contacts.
⁎ Correlation signiﬁcant at .05 level (2-tailed).
⁎⁎ Correlation signiﬁcant at .01 level (2-tailed).
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outcome for perceived distress. In both studies, the patients’ abilities
to provide a picture of their life situations were limited; these ﬁndings
were thus similar to those of two other recent studies (Durand et al.,
2015; Gould et al., 2015). Therefore, the consequence of only using
self-assessments is that they constitute an incomplete basis for deci-
sions regarding the speciﬁc treatment required. Hence, if assessments
of intervention needs are based solely on self-ratings, the patient runs
the risk of not receiving the proper treatment. If, for example, deteriora-
tion in health is not identiﬁed in its early stages, there is an increased
risk that potential outpatient interventionswill not be initiated. Instead,
the patientmay have to be admitted and subsequently submit to avoid-
able hospitalization (Bianco et al., 2012; Woodhams et al., 2012).
There was no signiﬁcant difference between remission and non-
remission groups regarding perceived distress. This ﬁndingmay explain
why patients often lack motivation to receive support and treatment
(Mwansisya et al., 2013; Olsson, Larsson, Flensner, & Bäck-Pettersson,
2012). Previous research has, based on remission status, shown that
symptoms and functioning affect a patient’s everyday life (Haynes
et al., 2012; Jedrasik-Styla et al., 2012; Kim et al., 2013). However, the
relationship between remission and quality of life is not clear-cut,
which is most likely because of the different measurement approaches.
For example, the results of this study were in contrast to the results of
Pinna et al. (2013), who determined that patient self-rated experiences
of life quality were not associated with remission status.Table 3
Mean Values and Standard Deviations for the Patient-Rated Variables of Distress (PGD) and Qu
Remission
M SD
PGD 77.15 69.86
GQL 70.38 22.03
PANSS positive 9.22 2.67
PANSS negative 11.53 4.21
PANSS general 22.75 5.51
GAF-S symptoms 49.06 8.83
GAF-F functioning 49.85 9.66
S-C
days of hospitalization
4.32 18.34
S-C
housing arrangements
29.06 97.93
S-C capacity to work 1.51 0.95
S-C social contacts 3.70 0.56
Note. Also, the nurse assessments (PANSS, GAF, and S-C) are given as references. Differences in
⁎ t-test signiﬁcant at .05 level (2-tailed).
⁎⁎ t-test signiﬁcant at .01 level (2-tailed).
⁎⁎⁎ t-test signiﬁcant at .001 level (2-tailed).An alternative explanation for the lack of correlation between pa-
tient and nurse assessments could be related to the design of the instru-
ments. In particular, previous research highlighted the difﬁculties in
reaching a consensus on how well-being should be measured
(Schrank et al., 2013). At the same time, the PANSS (positive, negative,
and general symptoms) provides a picture of the speciﬁc symptoms
the patient has and how severe they are, but it does not capture the pa-
tient’s experience of distress (Kay et al., 1987; Lindström et al., 1994).
The GAF (symptoms and functioning) has a higher correlation with pa-
tient ratings compared with the PANSS, but it lacks the link to the sub-
jective experience of distress and quality of life — as does the PANSS
(American Psychiatric Association, 2013; Luborsky, 1962). However,
with the help of the PANSS and the GAF, nurses capture current symp-
toms that distress the patients and also register how they affect func-
tional capacity; these factors have a high mutual correlation.
Themajority of the nurse assessments in our studywere signiﬁcant-
ly correlated to each other, both for patients in remission and for those
in non-remission. These ﬁndings highlight the value of nurse assess-
ments in the planning of patient treatment. Moreover, the results of
nurse assessments must be discussed with the patients for them to
understand and be motivated to handle their situation (Hedberg,
Johanson, & Cederborg, 2008; Rothrock et al., 2010; van Wel &
Landsheer, 2012). Although nurse assessments are often the starting
point for patient care, more information is required to achieve success.
Different types of treatment models, such as the Assertive Communityality of Life (GQL) for Patients in Remission and Non-Remission.
Non-remission Results of independent t-tests
M SD p
71.52 93.22 0.575
64.51 22.80 0.038⁎
15.61 5.27 b0.001⁎⁎⁎
19.41 6.89 b0.001⁎⁎⁎
32.59 8.13 b0.001⁎⁎⁎
40.93 4.42 b0.001⁎⁎⁎
43.35 6.41 b0.001⁎⁎⁎
6.89 23.98 0.319
71.06 141.69 0.004⁎⁎
1.33 0.71 0.112
3.22 0.91 b0.001⁎⁎⁎
the mean values were compared with independent t-tests.
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encourage them to actively participate in their treatment. However, as
previously discussed, our study indicates that there is a potential prob-
lem of basing decisions for necessary treatment interventions solely on
patient self-assessments of mental health status. In contrast, our results
underline the importance of nurse assessments of patients with the aid
of assessment instruments. In addition to practical measures to ensure
that the basic needs of patients are met, processes are also required in
which the nurses’ reﬂections and assessments are utilized (Kitson,
Muntlin Athlin, & Conroy, 2014). It is important to have an integrated
strategy to ensure that patients receive the appropriate support and
care interventions for their symptoms and needs (Morgan et al., 2012;
Werner, 2012). This strategy requires a broad collaboration between
various professions in the outpatient care teams. However, to achieve
an optimalwork approachwhere established assessment scales are cor-
rectly used to describe patient situations, nurses who perform these as-
sessments must receive education, continuous practice and regular
calibration to maintain quality of their estimates. Skills related to put-
ting interview questions to the patient in the right way, to listen and
see the patient, and to catch up on symptoms and possible side effects,
are of crucial importance. Recent research also points out the possibili-
ties of psychological training for patients to achieve compensatory
strategies to increase their self-awareness (Gould et al., 2015), which
might result in more accurate self-assessments. It is also highly impor-
tant that the nurse makes an accurate assessment based on all informa-
tion collected in relation to the speciﬁc criteria for each rating scale.
Finally, to use the information obtained in a clinically relevant way
when meeting the patient and other professionals also requires
knowledge and competence from the nurse regarding to how different
assessment scales work.
METHODOLOGICAL CONSIDERATIONS AND LIMITATIONS
The self-assessments in our study only represented one assessment
occasion per patient. Moreover, our sample was a heterogeneous group
of patientswhose experiences of self-assessments ranged from relative-
ly inexperienced to experience with self-rating on several occasions.
Presumably, this range of assessment experiences could provide an
overview of the ability of outpatients with schizopsychotic illness to
conduct self-assessments. This study does not, however, indicate how
the individual patient rates his or her perception of distress and quality
of life over time, thus highlighting the need for further research.
CONCLUSIONS AND PRACTICAL IMPLICATIONS
Our results demonstrate that patient self-ratings do not correlate
with nurse assessments. Therefore, there is a risk that the information
regarding mental health status reported by the patient is insufﬁcient
to ensure that necessary care interventions are undertaken. Moreover,
our ﬁnding that patients’ perceived distress is not associated with
their remission status implies that treatment, and the evaluation of
treatment, should not be solely based on reported information. The
self-assessments do not constitute a sufﬁcient basis to determine the
speciﬁc interventions required; thus, these ﬁndings suggest that care
cannot be developed by giving the individual patient greater responsi-
bility. However, nurse assessments provide relevant information re-
garding patient functioning. Thus, nurses need further training to be
able to communicate the patients’ situations based on the results from
their assessments with evidence-based instruments. The need for
nurses to have these accurate skills and knowledge regarding assess-
ments should therefore be reﬂected in clinical guidelines as well as in
curricula for nursing studies.
The results of this study highlight the need for further research. To
investigate if patients’ abilities to conduct self-assessments could be im-
proved by repeated assessment occasions, a longitudinal descriptive
and explorative study is planned. Self-rating scales carried out bypatients, and semi-structured interviews with related assessment
performed by nurses will be longitudinally compared. Further, there
should also be qualitative research investigating patients’ experiences
and reasoning when conducting self-ratings. This could lead to a
better understanding of the self-rating process with its shortcomings
and advantages.
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